. How Breast Cancer Research and Treatment Has Evolved « JO LEE MAGAZINE

Vice- It’s a sobering stat: 13% of US women will develop invasive breast cancer in their lifetime. In 2019, Taryn Southern became one of them. She chronicled her treatment journey online, from chemo to surgery and radiation, and antibody infusions to targeted therapies. Some of the latter are relatively new, and had Southern been diagnosed 15 to 20 years ago the treatment options wouldn’t have been as robust. Back then, “if you were diagnosed with breast cancer, everyone was treated the same, given the same chemotherapy,” says Astrid Ruefli-Brasse, Vice President of Tumor Biology, Pfizer Oncology. “But now,” she continues, “because we understand much more what’s happening at a molecular level, we’re able to develop therapies that are specific for those molecular changes.”

To Read More

Comments are closed.